IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
0.9746
+0.0356 (3.79%)
At close: Dec 11, 2025, 4:00 PM EST
0.9705
-0.0040 (-0.42%)
After-hours: Dec 11, 2025, 4:04 PM EST
IRIDEX Market Cap
IRIDEX has a market cap or net worth of $16.75 million as of December 11, 2025. Its market cap has decreased by -43.97% in one year.
Market Cap
16.75M
Enterprise Value
15.83M
1-Year Change
-43.97%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since December 1, 1998, IRIDEX's market cap has decreased from $26.00M to $16.75M, a decrease of -35.57%. That is a compound annual growth rate of -1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 16.10M | -42.29% |
| Dec 31, 2024 | 27.90M | -38.95% |
| Dec 29, 2023 | 45.70M | 42.37% |
| Dec 30, 2022 | 32.10M | -66.87% |
| Dec 31, 2021 | 96.90M | 177.65% |
| Dec 31, 2020 | 34.90M | 13.68% |
| Dec 31, 2019 | 30.70M | -51.96% |
| Dec 31, 2018 | 63.90M | -27.55% |
| Dec 29, 2017 | 88.20M | -38.19% |
| Dec 30, 2016 | 142.70M | 54.44% |
| Dec 31, 2015 | 92.40M | 9.22% |
| Dec 31, 2014 | 84.60M | -15.15% |
| Dec 31, 2013 | 99.70M | 184.86% |
| Dec 31, 2012 | 35.00M | 4.48% |
| Dec 30, 2011 | 33.50M | -4.83% |
| Dec 31, 2010 | 35.20M | 29.41% |
| Dec 31, 2009 | 27.20M | 262.67% |
| Dec 31, 2008 | 7.50M | -65.28% |
| Dec 31, 2007 | 21.60M | -68.92% |
| Dec 29, 2006 | 69.50M | 18.00% |
| Dec 30, 2005 | 58.90M | 88.18% |
| Dec 31, 2004 | 31.30M | -17.41% |
| Dec 31, 2003 | 37.90M | 89.50% |
| Dec 31, 2002 | 20.00M | -38.46% |
| Dec 31, 2001 | 32.50M | - |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |